SecBot SecBot
SECBOTREPLAY Home › Report › ZYME

ZYME · Zymeworks announced the acceptance of an oral presentation and six…

Zymeworks Inc. · PRESS-RELEASE filed Mar 17, 2026 at 17:02 ET

At the news

NEUTRALIMPACT 3/10

PRESS-RELEASE filed Mar 17, 2026 at 17:02 ET

Zymeworks announced the acceptance of an oral presentation and six abstracts from its R&D portfolio for presentation at the 2026 AACR Annual Meeting. This highlights ongoing research activity but does not represent a material clinical or regulatory milestone.

  • Zymeworks will present one oral presentation and six posters at the AACR Annual Meeting 2026.
  • Presentations are from the company's wholly-owned R&D portfolio.
  • Event takes place April 17–22, 2026, in San Diego, CA.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access